Health Canada Adds Warning of Very Rare, Serious Condition as Potential Side Effect

Health Canada Adds Warning of Very Rare, Serious Condition as Potential Side Effect
Vials of the AstraZeneca COVID-19 vaccine sit in a fridge at the local vaccine center in Ebersberg near Munich, Germany. March, 22, 2021. (The Associated Press/Matthias Schrader/File)
The Canadian Press
Updated:

OTTAWA—Health Canada is updating the label for the Oxford-AstraZeneca and COVISHIELD COVID-19 vaccines to add capillary leak syndrome as a potential side-effect.

The agency is also including a warning for patients with a history of the ailment to not get those vaccines.